N-allyl analogues of phencyclidine: chemical synthesis and pharmacological properties.
Several N-allyl derivatives of 1-phenylcyclohexylamine (PCA) were prepared, and their pharmacology was briefly characterized. The mono- and diallyl derivatives had phencyclidine-like activities in mice but were less potent behaviorally than phencyclidine (PCP). None were PCP antagonists. In vitro these compounds were competitive inhibitors of butyrylcholinesterase (BChE) and protected against inhibition by DFP. In addition, these agents displaced tritiated N-methyl-4-piperidyl benzilate from mouse-brain homogenates and inhibited the effects of acetylcholine on isolated guinea pig ileum. None of these in vitro effects correlated with their PCP-like behavioral activity in vivo in mice.
D000818:Animals; D001921:Brain / Q000378:metabolism; D002091:Butyrylcholinesterase; D055598:Chemical Phenomena; D002621:Chemistry; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004347:Drug Interactions; D006168:Guinea Pigs; D006736:Horses; D007082:Ileum / Q000187:drug effects; D007531:Isoflurophate / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009043:Motor Activity / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D010622:Phencyclidine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains; D011976:Receptors, Muscarinic / Q000187:drug effects; D013329:Structure-Activity Relationship
D002800:Cholinesterase Inhibitors; D011976:Receptors, Muscarinic; D007531:Isoflurophate; D002091:Butyrylcholinesterase; D010622:Phencyclidine